Clinical trial
Clinical Trial Phase I / II to Evaluate the Safety and Efficacy of the Infusion of Autologous CD34 + Cells Transduced With a Lentiviral Vector Carrying the Gene FANCA in Patients With FA Subtype A (FANCOLEN-1)
NCT03157804 is registered in ClinicalTrials.gov with Hospital Infantil Universitario Niño Jesús, Madrid, Spain as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Trial Phase I / II to Evaluate the Safety and Efficacy of the Infusion of Autologous CD34 + Cells Transduced With a Lentiviral Vector Carrying the Gene FANCA in Patients With FA Subtype A (FANCOLEN-1)
- Lead sponsor
- Hospital Infantil Universitario Niño Jesús, Madrid, Spain
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- January 7, 2016
- Completion date
- September 8, 2023
- Enrollment
- 9 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.